Literature DB >> 29078767

Correction to: Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study.

Soy Ty Kheang1, Siv Sovannaroth2, Sovann Ek3, Say Chy3, Phally Chhun3, Sokkieng Mao3, Sokomar Nguon3, Dy Soley Lek2, Didier Menard4, Neeraj Kak3.   

Abstract

After publication of the article [1], it has been brought to our attention that the funding acknowledgements for this article are incomplete. The authors would like to also include the following.

Entities:  

Year:  2017        PMID: 29078767      PMCID: PMC5660448          DOI: 10.1186/s12936-017-2073-8

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


Correction to: Malar J (2017) 16:372 DOI 10.1186/s12936-017-2024-4

After publication of the article [1], it has been brought to our attention that the funding acknowledgements for this article are incomplete. The authors would like to also include the following: “The URC staff participating in this study were funded by the President's Malaria Initiative/United States Agency for International Development (PMI/USAID) under AID-486-A-12-00001—Control and Prevention of Malaria (CAP-Malaria) and AID-442-C-17-00001—Cambodia Malaria Elimination Project (CMEP) projects.”
  1 in total

1.  Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study.

Authors:  Soy Ty Kheang; Siv Sovannaroth; Sovann Ek; Say Chy; Phally Chhun; Sokkieng Mao; Sokomar Nguon; Dy Soley Lek; Didier Menard; Neeraj Kak
Journal:  Malar J       Date:  2017-09-13       Impact factor: 2.979

  1 in total
  1 in total

1.  K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors.

Authors:  Moses Ocan; Dickens Akena; Sam Nsobya; Moses R Kamya; Richard Senono; Alison Annet Kinengyere; Ekwaro Obuku
Journal:  Malar J       Date:  2019-03-07       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.